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Abstract We have delivered viral vectors containing either Chop2 fused with GFP, Channelrhodopsin-2（ChR2）,
or Halorhodopsin（HaloR）fused with mCherry（to form light gated cation channels or chloride pumps, respectively）,
into the dorsal cochlear nucleus（DCN）. One to eighteen months later we examined the CN and inferior colliculus
（IC）for evidence of virally transfected cells and processes. Production of ChR2 and HaloR was observed throughout
the DCN. Rhodopsin localization within neurons was determined, with elongate, fusiform and giant cells identified
based on morphology and location within the DCN. Production of ChR2 and HaloR was found at both the injection
site as well as in regions projecting to and from the DCN. Light driven neuronal activity in the DCN was dependent
upon the wavelength and intensity of the light, with only the appropriate wavelength resulting in activation and higher
intensity light resulting in more neuronal activity. Transfecting cells via viral delivery of rhodopsins can be useful as
a tract tracer and as a neuronal marker to delineate pathways. In the future rhodopsin delivery and activation may be
developed as an alternative to electrical stimulation of neurons.
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Introduction
Microbial channelopsins have been cloned and when
functionally expressed were found to form light-
gated cation channels （ChR2） and chloride pumps
（HaloR）. 1-5 Recently, several studies have been able to
take advantage of these rhodopsin proteins. Once ChR2
and HaloR are inserted into the cell membrane a neuron
can be depolarized or hyperpolarized remotely via specif⁃
ic wavelengths of light. 6-7 Even ectopic expression of
one of these channelopsins, channelrhodopsin-2
（ChR2）, was able to restore visual responses in mice
with photoreceptor degeneration. 8
With the proliferation of cochlear prosthetic devices
that are implanted at various levels of the auditory sys⁃
tem becoming a routine treatment for profound deafness
in both young people and adults, developing the best
possible device for implantation as well as providing the
best possible platform for the reintroduction of hearing
by understanding the effects of implantation and stimula⁃
tion becomes critical. In the auditory system, restoration
of hearing with cochlear prostheses is achieved through
spread of electrical currents to neurons that are in direct
contact with the implanted electrodes. The spatial sensi⁃
tivity of this approach is limited by the spread of cur⁃
rent. Recent approaches using lasers 9, 10 to stimulate au⁃
ditory neurons are able to activate specific regions of the
cochlea thereby controlling the spread of activity provid⁃
ing discrete control of groups of neurons.
In the current study our goals were to determine
whether constructs containing ChR2 and HaloR would
be expressed across cell types in the DCN, how long the
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expression would persist, whether rhodopsin expression
was restricted to ascending and descending pathways re⁃
lated to the injection site and whether appropriate wave⁃
lengths of light could activate neurons in vivo.
In the future, transfection of neurons with ChR2 and
HaloR will allow us to take advantage of a non-contact
approach for neuronal stimulation and will provide us
with the advantage of being able to target specific cell
types with designer channelopsins activated by different
wavelengths of light ultimately resulting in more precise
control of the auditory experience.
Methods
Stereotaxic delivery of rhododpsins
Normal hearing male Sprague Dawley rats（n=15）
were anesthetized with a mixture of xylazine（8 mg/kg）
and ketamine（75 mg/kg） by intramuscular injection
and body temperature was maintained with a water
re-circulation heating pad. Using stereotaxic coordi⁃
nates consistent with Paxinos and Watson（AP 11.6 mm
relative to bregma, ML 3.2 mm from midline and DV 4.9
mm from pia） injections were made into the caudal
DCN. Adeno-associated virus 2（AAV2）with a GFP
（ChR2） or cytomegalovirus（CMV） with a mCherry
（Halo-rhodopsin）tag was injected bilaterally（1μl）us⁃
ing a Hamilton Syringe with 33-gauge needle. Follow⁃
ing the injection the needle remained in place for five
minutes before removal. The viral constructs used in
this study have been previously described 8，６，11 and
kindly provided by Dr. Z-H Pan（Wayne State Universi⁃
ty, Detroit, MI）.
Histology
Tissue from the brain was collected from 15 animals
three weeks to 18 months after injection (ChR2 n = 11;
HaloR n = 4). Animals were transcardially perfused with
9.25 % sucrose followed by 4% paraformaldehyde in 0.1
M PBS (pH 6.8). Brains were post-fixed in the same
paraformaldehyde solution for 1 hr at room temperature
and then placed in 30% sucrose for 24-48 hrs at 4℃ .
The fixed and cryo-protected tissues were cut with a
cryostat into 30 ~ 40 μm sections and stored on glass
slides at -80℃ . Sections from auditory (DCN, VCN,
SOC and IC) as well as extra-auditory (cerebellum and
inferior olive) regions were examined for ChR2-GFP or
HaloR-mCherry fluorescence.
Immunocytochemistry
In order to determine whether rhodopsin expression
was neuronal, GFP were examined for co-localization
with the neuronal markers MAP2 and TUJ1. Sections
through the DCN were incubated with a mixture of pri⁃
mary antibodies; mouse anti-MAP-2（microtubule asso⁃
ciated protein-2, cat. # MAB3418, Chemicon, Temecu⁃
la, CA; 1∶200）and mouse anti-TUJ1 (class III be⁃
ta-tubulin, cat. #MAB1637, Chemicon; 1∶200). After
24 hours at room temperature in a dark humid chamber,
the sections were rinsed and the tissue incubated with a
fluorophore conjugated secondary antibody (Cy3 donkey
anti-mouse; 1∶500 Jackson ImmunoResearch, West
Grove, PA).
All images were visualized and captured with a Leica
Microscope (DM 5000B) equipped with appropriate fluo⁃
rescence filters, a Cool Snap EZ monochrome camera
and Elements software (Photometrics Ann Arbor, MI).
Figures were compiled using Adobe Photoshop software
to combine, size and adjust the brightness and contrast
of selected images.
Photostimulation of DCN neurons
Extracellular recordings were obtained from rats in⁃
jected with ChR2 (n=4) and from non-injected rats (n=
3). Following xylazine (8 mg/kg) and ketamine (75 mg/
kg) anesthesia, the occipital bone was exposed and re⁃
moved just above the caudal DCN. A small portion of
the cerebellum covering the surface of the DCN was
carefully removed via suction until the DCN was clearly
visible. All surgical procedures were performed under
sterile conditions and body temperature was monitored
and maintained at normal temperatures with a heating
pad.
Field potential responses were monitored with a sin⁃
gle shank five channel electrode (NeuroNexus Technolo⁃
gies, Ann Arbor MI and a gift from Univ. of Michigan
KHRI). Each channel was separated by 100 μm respec⁃
tively. The probes were visually placed and guided into
the DCN using a stereotaxic frame to lower the electrode
500 μm below the surface. A grounding electrode was
placed just under the skin near the scapula. A royal
blue light-emitting diode (LED) with a spectrum rang⁃
ing from 440-460 nm and a peak of 455 nm
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(LXHL-LR5C, Luxeon Brantford, Ontario, Canada) was
used for activation of ChR2 (460 nm; ChR2 optimal
wavelength) while an amber LED with a spectral range
of 585-597 nm and a peak spectrum of 590 nm
(LXHL-LL3C, Luxeon Brantford) was used for activa⁃
tion as a control stimulation. Both the royal blue LED
(7.0 v, 8. 96 × 1016 photons/cm2/s) and the amber LED
(2.9 v, 1.01×1016 photons/cm2/s) were placed 2 cm above
the DCN for stimulation.
The light pulses were generated by a relay board
(WINFORD RLY102) and controlled by an oscilloscope
with a trigger (LG Precision Co. OS-5020G). Each LED
emitted light at a rate of 5 cycles/s (1 cycle = light on
100 ms + light off 100 ms). Three trials lasting 5, 10,
Figure 1 Channel rhodopsin (ChR2) can be produced in DCN neurons. Following a single injection of AAV2 containing the
ChR2-GFP construct, labeling was observed throughout the DCN (A-B). Small cells were identified in DCN1 (C), while several cell
types including fusiform and giant cells were labeled in DCN2 and DCN3 (C - F). Arrow in C indicates fusiform cell (enlarged in E)
and arrow in D indicates giant cell (enlarged in F). Arrows in E point to spines on dendrites, perhaps indicating the location of syn⁃
aptic inputs. Scale bar in B also valid for A and scale bar in D is also valid for C. Cb-cerebellum; DCN-dorsal cochlear nucleus;
PVCN-posteroventral cochlear nucleus; icp-inferior cerebellar peduncle; sp5-spinal trigeminal tract; DCN1-molecular layer of the
DCN; DCN2-fusiform layer of the DCN; DCN3-deep layer of DCN
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Figure 2 Channel rhodopsin (ChR2) is produced in neurons. When ChR2 labeling (A) is combined with immunocytochemistry for
the neuronal markers MAP2 and TUJ1 (B), double labeling of neurons can be observed in the dorsal cochlear nucleus (C).
Figure 3 Halo-rhodopsin (HaloR) can be produced in DCN neurons. Following a single injection of CMV containing the
HaloR-mCherry construct, labeling was observed throughout the DCN (A-B). Small cells were identified in DCN1 (C), while several
cell types including fusiform and giant cells were labeled in DCN2 and DCN3 (C - F). Box in C indicates labeling in DCN2 (enlarged
in D) and box in E indicates labeling in DCN3 (enlarged in F). Arrow in D points to a fusiform cell and arrow in F indicates a giant
cell. Scale bar in B also valid for A. Cb-cerebellum; DCN-dorsal cochlear nucleus; PVCN-posteroventral cochlear nucleus; icp-infe⁃
rior cerebellar peduncle; DCN1-molecular layer of the DCN; DCN2-fusiform layer of the DCN; DCN3-deep layer of DCN
and 20 seconds were repeated 3 times each for each
LED. Between each trial there was a 30 second recov⁃
ery time without any light stimulation. The evoked sig⁃
nals were amplified using a pre-amplifier and a MICRO
1401Ⅱ amplifier with data recorded using Spike2 Soft⁃
ware (v 4.20).
All procedures were approved by the Wayne State
School of Medicine“Laboratory Animal Care and Use
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Committee”(PHS Animal Welfare Assurance number
A3310-01) and conform to the National Institutes of
Health guidelines.
Results
Both ChR2 and HaloR can be expressed and pro⁃
duced in DCN neurons
ChR2-GFP Within five weeks of stereotaxic injec⁃
tion the expression and production of ChR2-GFP was
observed in all layers of the DCN, with the heaviest fluo⁃
rescence observed in DCN2 and DCN3 (Figure 1).
Many of the GFP producing cells were also labeled for
the neuronal marker MAP2 and TUJ1 (Figure 2). Fluo⁃
rescence for ChR2-GFP was observed throughout the
neurons, including somata, dendrites and axon terminals
(Figures 1 and 2) with heavier labeling in cell mem⁃
branes as well as on dendritic spines and axonal varicos⁃
ities (See Figure 1E arrows). Labeling was not restricted
to a specific type of neuron or neurotransmitter class.
Cell types included fusiform, giant, elongate as well as
cartwheel cells.
HaloR-mCherry Just as found with ChR2-GFP ex⁃
pression, production of HaloR-mCherry was observed in
all layers of the DCN (Figure 3) with the strongest fluo⁃
rescence observed in the fusiform (layer two) and the
deep core (layer three) layers. Many different cell types
within the DCN, including fusiform and giant cells were
capable of producing the HaloR-mCherry fusion protein
driven by the CMV promoter. Somata, dendrites and ax⁃
ons show a more diffuse labeling when compared to the
production of ChR2 (compare Figure 3 to Figure 1).
The ChR2-GFP and HaloR-mCherry constructs can
trace neuronal pathways
We have determined that other regions of the auditory
brainstem exhibit ChR2 and HaloR expression five
weeks following a pressure injection of ChR2-GFP or
HaloR-mCherry into the DCN. Both ChR2-GFP(Figure
4A-C) and HaloR-mCherry (Figure 4D-F) production
was observed in the contralateral IC, most robustly in
the central nucleus. As expected, the production ob⁃
served in the IC was primarily localized to terminals
(Figure 4C and 4F) presumably associated with somata
located in the DCN. The injection site often included a
small region of the cerebellum, the interpositus nucleus
(Int). The Int sends and receives projections from the in⁃
ferior olive (IO). Labeled ChR2-GFP somata were ob⁃
Figure 4 Channel rhodopsin (ChR2) and Halo-rhodopsin (HaloR) can be produced throughout DCN neurons. Following an in⁃
jection of AAV2 containing the ChR2-GFP（green）or CMV containing the HaloR-mCherry（red）construct, labeling was ob⁃
served in the inferior colliculus (A-F). For both ChR2 (A-C) and HaloR (D-F) labeling was primarily observed in terminals lo⁃
cated within the CNIC (B and E) with sparse labeling in the DCIC (C and F).
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served in the Int (Figure 5A-D) while terminals were
found in the IO (Figure 5E-F) the downstream target of
Int neurons. Different cell types could be identified de⁃
pending upon the region of the Int observed. In the IntA
(Figure 5C) cells with small somata (≤10 μm diameter)
and a single dendrite expressed ChR2-GFP, while cells
in the IntDL(Figure 5D) expressing ChR2-GFP had larg⁃
er somata (≥20 μm diameter) with multiple dendrites.
Photostimulation of ChR2 transfected DCN neurons
is wavelength and intensity dependent
For light activation of ChR2-GFP neurons, an LED
was placed 2 cm above the DCN, which had been surgi⁃
cally exposed. A light with a wavelength centered
around 460 nm should open ion channels in neurons pro⁃
ducing ChR2-GFP. To determine whether the effects of
wavelength and intensity of light on neuronal activity we
first exposed the ChR2 transfected DCN to three differ⁃
ent intensities of blue light, (Figure 6A 8.60 × 1016, 6B
Figure 5 Production of channel rhodopsin (ChR2-GFP) can be used to trace neuronal pathways. Injection of the interpositus nucle⁃
us of the cerebellum (A-B) labels somata and dendrites in both the IntA (C) and the IntDL (D), both of which send projections to the
IO (E-F). Box in B indicates region labeled in A. IntDM-dorsal medial interpositus nucleus; IntDL-dorsal lateral interpositus nucle⁃
us; IntA-anterior interpositus nucleus; IntDL-dorsal lateral interpositus nucleus; IO-inferior olive; py-pyramid
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Figure 6 Optical activation of ChR2 producing neurons is intensity and wavelength specific. Using 455 nm light (A-D) neuronal
activity in the DCN was compared at 8.60 × 1016 (A), 8.82 × 1016 (B), and 8.95 × 1016 photons/cm2/s (C) during three trials in which
the light was on for ~10 s (indicated by horizontal bars in A-C) and off for ~10s. The most robust activation was observed during the
highest intensity of light stimulation (C-D). Exposure to 590 nm light (light on indicated by horizontal bars in (E-G) did not produce
activation of ChR2 infected neurons at any of the intensities tested (E-H). The Y axis (D and H) indicates standard deviation while
the X axis shows the effects of different intensities of 455 nm light (D) and 590 nm light (H). Asterisks indicate significant differenc⁃
es（P⦤ 0.05）.
Figure 7 Light stimulation of DCN neurons transfected with ChR2. In animals that did not receive an injection of AAV2
ChR2-GFP (control), no neuronal activation was observed during exposure (horizontal lines) to blue (455 nm) light (A) or amber (590
nm) light (B). However, animals injected with AAV2 ChR2-GFP showed increased neuronal activity during trials when exposed to
455 nm light for 10, 5, or 20 seconds (C), but no change in activity was observed when exposed to amber (590 nm) light (D). Standard
deviation (SD) was compared when the blue (455 nm) light was on versus when the light was off in both control and ChR2 injected ani⁃
mals (E) with the most robust increase in SD observed in the ChR2 injected animals when the blue light was on. Changes in SD were
also compared when the amber (590 nm) light was on versus off in control and ChR2 injected animals (F). Horizontal lines in each
panel denote times during which the light was on. Blue-exposure to 455 nm light; Amber-exposure to 590 nm light
8.82 × 1016, 6C 8.95 × 1016 photons/cm2/s) for three 10
second intervals. As the intensity of light increased from
8.60 × 1016 to 8.95 × 1016 photons/cm2/s (Figure 6 A-D)
there was an increase in standard deviation (SD) ob⁃
served between the light off vs the light on. However, the
lowest intensity of blue light (8.60 × 1016 photons/cm2/s )
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resulted in no significant change in SD (Figure 6A and
6D). The two higher intensities resulted in significant in⁃
creases in SD (150% p = 0.0001 and 200% p = 0.0138
respectively) when the light was on (Figure 6D) com⁃
pared to light off. The DCN was then exposed to a differ⁃
ent wavelength of light, amber (centered around 590
nm), also at three different intensities (Figure 6E 6.87 ×
1015, 6F 9.62 × 1015, 6G 1.01 × 1016 photons/cm2/s ). The
amber light resulted in no significant difference in the
SD observed between the light on and the light off condi⁃
tion (Figure 6H).
Light activates DCN neurons producing either
ChR2-GFP
In control animals with no ChR2-GFP injection, re⁃
gardless of whether the LED emitted light at wave⁃
lengths of 455 nm (Figure 7A) or 590 nm (Figure 7B), no
changes in neuronal activity were observed in the DCN
when comparing light on (10, 5 and 20 seconds ×3) vs
light off conditions (30 seconds per trial). However, in
animals with viral delivery of ChR2-GFP constructs to
the DCN, exposure of neurons to 455 nm of light result⁃
ed in more neuronal activity corresponding to the time
(10, 5 , and 20 seconds) of the light exposure as com⁃
pared to when the light was off (Figure 7C). We did not
detect changes in multiunit activity when the same neu⁃
rons in animals with viral delivery of ChR2-GFP con⁃
structs were exposed to 590 nm of light (Figure 7D).
When comparing the light on condition with the light off
condition during exposure to blue light (Figure 7E) vs
amber light (Figure 7F), control animals sometimes
showed small, but significant increases (0.168±0.004 off
0.174 ± 0.007 on; p = 0.035) during stimulation with
blue light. However, the ChR2-GFP injected animals re⁃
liably resulted in robust significant increases in stan⁃
dard deviation (0.185 ± 0.002 off 0.389 ± 0.022 on; p =
3.8 × 10-9) when the blue light was“on”(Figure 7E) sug⁃
gesting that repeated exposure to wavelengths of 455 nm
of light resulted in corresponding increases in multiunit
activity. During 590 nm light exposure (Figure 7F), nei⁃
ther controls (0.288 ± 0.005 off 0.389 ± 0.286 on; p =
0.466) nor ChR2-GFP injected animals (0.158 ± 0.002
off 0.163 ± 0.002 on; p = 0.186) demonstrated a signifi⁃
cant difference in standard deviation when the amber
light was“on”. Regardless of whether ChR2-GFP trans⁃
fected cells were activated for 5, 10 or 20 seconds, no
diminution in signal was observed during a trial (Figure
7C).
Discussion
In the current study we have demonstrated that viral
delivery of ChR2 or HaloR into the DCN results in ex⁃
pression within neurons and terminals within all layers
of the DCN. Specifically, we identified ChR2 labeling in
fusiform, elongated and giant cells. Each of these neu⁃
rons has previously been identified and associated with
specific layers of the DCN. Our results are similar to
those recently reported where ChR2 was virally targeted
to neurons in the retina and auditory cortex. 6, 7 The re⁃
sults of our immunocytochemistry with MAP2 and TUJ1
support our hypothesis that the majority of the ChR2-la⁃
beled cells in the DCN following viral targeting are neu⁃
rons. Suggesting that DCN neurons contain the genetic
machinery necessary to express and produce
ChR2-GFP. In addition, we demonstrate results from
the viral-targeted expression of light activated chloride
pumps (HaloR) in DCN neurons. Like ChR2-GFP, pro⁃
duction of HaloR-mCherry was observed in neurons
within each layer of the DCN.
Gene transfer of ChR2-GFP and HaloR-mCherry re⁃
sulted in labeling of neuronal somata and terminals.
This ability of ChR2-GFP and HaloR-mCherry to be
produced throughout the neuron allowed us to identify
projections of DCN and cerebellar neurons. Unlike the
herpes simplex virus (HSV) that has been used to medi⁃
ate gene transfer of ChR2 in the auditory cortex7 the
AAV2 that was used in the current study does not cross
synapses. Therefore, a neuron that produces ChR2-GFP
had direct contact with the virus and may be identified
in regions that have known connections with the injected
area (DCN or cerebellum). In the current study the trac⁃
er aspect of AAV2 appeared to be primarily anterograde
in nature as has been noted previously in the brain.12
These results suggest that viral delivery of ChR2 and
HaloR can be said to be a useful tool from the histologi⁃
cal standpoint alone even excluding physiological
views.
Using light with a wavelength compatible with ChR2
activation, responses were evoked and recorded from
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DCN neurons. However, the responses were dependent
upon the light intensity with little depolarization ob⁃
served with lower intensity light. The lack of responses
observed when using amber light suggests that the ob⁃
served neuronal activity was ChR2 specific and that fac⁃
tors such as heat from the LED or current changes from
LED pulses do not contribute to the responses. The fact
that ChR2 responses in DCN neurons increase immedi⁃
ately after the onset of light stimulation, is sustained for
the duration of the light exposure and returns to back⁃
ground levels immediately after light stimulation is
stopped, suggests that ChR2 stimulation may be able to
be precise, reliable and performed on a time scale func⁃
tionally relevant for CN neurons.
Currently implants designed restore hearing in the
profoundly deaf comprise use electrical current and mul⁃
tiple electrodes designed to stimulate many neurons
throughout the cochlea or a given brain region. The goal
is to provide local control of discrete neuronal popula⁃
tions in order to generate signals that convey high or low
frequency information depending on which neurons are
stimulated. However, caveats of using electrical current
to activate neurons in this manner include the inability
to control the spread of activity across different groups
of neurons decreasing the ability to clearly discriminate
sounds. Recently, the use of pulsed infrared optical radi⁃
ation has been used by others to activate spiral ganglion
cells providing more discrete stimulation of these neu⁃
rons allowing an increased number of independent
sub-populations of neurons to be stimulated for parallel
speech processing. 9 In the current study, transfecting
neurons with ChR2 allowed us to take advantage of a
similar non-contact approach.
In the future, cell type-specific promoters could be
used to target these rhodopsins to specific neuronal cell
types indentified such as the recently reported vGluT3
labeled neurons in the CN 13 or dopaminergic neurons
that have been previously identified in the inferior collic⁃
ulus. 14 This strategy offers the ability to avoid neuronal
damage by using light stimulation instead of electrical
current, more precisely target specific groups of neurons
and repetitively excite and/or inhibit these neurons as
necessary. Auditory neurons could be controled not by
sound but by light with rhodopsins someday. That must
be the great progress in the physiological, audiological
and clinical study.
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